Worldwide Clinical Trials has appointed industry veteran Alistair Macdonald as CEO, following Peter Benton’s retirement after more than a decade of leadership. Macdonald brings deep experience from Syneos Health and GHO Capital, and plans to scale global operations, expand therapeutic expertise, and invest in innovation—including AI—to meet evolving client and patient needs. Click here to read the full article.
